Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico

A. H. Saeidian, L. Youssefian, M. G. Moreno Trevino, G. Fortuna, H. Vahidnezhad, V. S. Atanasova, J. Uitto, J. C. Salas-Alanis, A. P. South

Research output: Contribution to journalArticle

Abstract

Recessive dystrophic epidermolysis bullosa (RDEB; OMIM #226600) is one of the most devastating subtypes of epidermolysis bullosa, a group of skin and mucous membrane blistering disorders often associated with extracutaneous manifestations. RDEB is caused by mutations in COL7A1, the gene encoding type VII collagen (C7), and to date over 700 different mutations in the 8835 nucleotides constituting the open reading frame or adjacent exon–intron boundaries of COL7A1 have been described. We used targeted next-generation sequencing to identify seven previously unreported mutations in a cohort of 17 Mexican patients who were diagnosed with RDEB based on clinical presentation and immunoepitope mapping. Our study expands the spectrum of mutations identified in this cohort, including those suitable for emerging therapies reliant on precise genotyping.

Original languageEnglish
Pages (from-to)579-584
Number of pages6
JournalClinical and Experimental Dermatology
Volume43
Issue number5
DOIs
Publication statusPublished - 1 Jul 2018

Fingerprint

Epidermolysis Bullosa Dystrophica
Mexico
Mutation
Collagen Type VII
Epidermolysis Bullosa
Genetic Databases
Open Reading Frames
Mucous Membrane
Nucleotides
Skin
Genes

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Saeidian, A. H. ; Youssefian, L. ; Moreno Trevino, M. G. ; Fortuna, G. ; Vahidnezhad, H. ; Atanasova, V. S. ; Uitto, J. ; Salas-Alanis, J. C. ; South, A. P. / Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico. In: Clinical and Experimental Dermatology. 2018 ; Vol. 43, No. 5. pp. 579-584.
@article{92478b2d2fe64facaaa88c81e6c18498,
title = "Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico",
abstract = "Recessive dystrophic epidermolysis bullosa (RDEB; OMIM #226600) is one of the most devastating subtypes of epidermolysis bullosa, a group of skin and mucous membrane blistering disorders often associated with extracutaneous manifestations. RDEB is caused by mutations in COL7A1, the gene encoding type VII collagen (C7), and to date over 700 different mutations in the 8835 nucleotides constituting the open reading frame or adjacent exon–intron boundaries of COL7A1 have been described. We used targeted next-generation sequencing to identify seven previously unreported mutations in a cohort of 17 Mexican patients who were diagnosed with RDEB based on clinical presentation and immunoepitope mapping. Our study expands the spectrum of mutations identified in this cohort, including those suitable for emerging therapies reliant on precise genotyping.",
author = "Saeidian, {A. H.} and L. Youssefian and {Moreno Trevino}, {M. G.} and G. Fortuna and H. Vahidnezhad and Atanasova, {V. S.} and J. Uitto and Salas-Alanis, {J. C.} and South, {A. P.}",
year = "2018",
month = "7",
day = "1",
doi = "10.1111/ced.13407",
language = "English",
volume = "43",
pages = "579--584",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "Wiley-Blackwell",
number = "5",

}

Saeidian, AH, Youssefian, L, Moreno Trevino, MG, Fortuna, G, Vahidnezhad, H, Atanasova, VS, Uitto, J, Salas-Alanis, JC & South, AP 2018, 'Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico', Clinical and Experimental Dermatology, vol. 43, no. 5, pp. 579-584. https://doi.org/10.1111/ced.13407

Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico. / Saeidian, A. H.; Youssefian, L.; Moreno Trevino, M. G.; Fortuna, G.; Vahidnezhad, H.; Atanasova, V. S.; Uitto, J.; Salas-Alanis, J. C.; South, A. P.

In: Clinical and Experimental Dermatology, Vol. 43, No. 5, 01.07.2018, p. 579-584.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico

AU - Saeidian, A. H.

AU - Youssefian, L.

AU - Moreno Trevino, M. G.

AU - Fortuna, G.

AU - Vahidnezhad, H.

AU - Atanasova, V. S.

AU - Uitto, J.

AU - Salas-Alanis, J. C.

AU - South, A. P.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Recessive dystrophic epidermolysis bullosa (RDEB; OMIM #226600) is one of the most devastating subtypes of epidermolysis bullosa, a group of skin and mucous membrane blistering disorders often associated with extracutaneous manifestations. RDEB is caused by mutations in COL7A1, the gene encoding type VII collagen (C7), and to date over 700 different mutations in the 8835 nucleotides constituting the open reading frame or adjacent exon–intron boundaries of COL7A1 have been described. We used targeted next-generation sequencing to identify seven previously unreported mutations in a cohort of 17 Mexican patients who were diagnosed with RDEB based on clinical presentation and immunoepitope mapping. Our study expands the spectrum of mutations identified in this cohort, including those suitable for emerging therapies reliant on precise genotyping.

AB - Recessive dystrophic epidermolysis bullosa (RDEB; OMIM #226600) is one of the most devastating subtypes of epidermolysis bullosa, a group of skin and mucous membrane blistering disorders often associated with extracutaneous manifestations. RDEB is caused by mutations in COL7A1, the gene encoding type VII collagen (C7), and to date over 700 different mutations in the 8835 nucleotides constituting the open reading frame or adjacent exon–intron boundaries of COL7A1 have been described. We used targeted next-generation sequencing to identify seven previously unreported mutations in a cohort of 17 Mexican patients who were diagnosed with RDEB based on clinical presentation and immunoepitope mapping. Our study expands the spectrum of mutations identified in this cohort, including those suitable for emerging therapies reliant on precise genotyping.

UR - http://www.scopus.com/inward/record.url?scp=85048993603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048993603&partnerID=8YFLogxK

U2 - 10.1111/ced.13407

DO - 10.1111/ced.13407

M3 - Article

AN - SCOPUS:85048993603

VL - 43

SP - 579

EP - 584

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 5

ER -